(R)-2-(3,5-Difluorophenyl)-2-hydroxyacetic acid, 98%, 1g

Ethyl 5-bromo-2-methyl-3-nitrobenzoate, 97%, 1g

1,1'-Bis(diisopropylphosphino)ferrocene>98.0%(T)1g

N-Ethyl-1,3-thiazol-2-amine, 96%, 250mg

(6-Chloro-2-methanesulfonyl-pyrimidin-4-yl)-cyclopropyl-amine, 2g

(1R,2R)-N1-(tert-Butoxycarbonyl)-1,2-cyclohexanediamine>98.0%(GC)(T)5g

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 97%, 1g

Tert-butyl n-[1-(aminomethyl)cyclobutyl]carbamate, 98%, 25g

Pentafluoro(4-methoxyphenyl)-lambda6-sulfane, 98%, 1g

(S)-2-Amino-2-(2,4-dichlorophenyl)ethanol hydrochloride, 95%, 100mg

tert-Butyl Ethyl Ether>95.0%(GC)5mL

Éter dietílico, ROTICHROM® GC, 5 ml, envase de vidrio

Moexipril hydrochloride, 98%, 250mg